489 related articles for article (PubMed ID: 12466138)
1. Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion.
Chatterjee G; Rosner A; Han Y; Zelazny ET; Li B; Cardiff RD; Perkins AS
Am J Pathol; 2002 Dec; 161(6):2241-53. PubMed ID: 12466138
[TBL] [Abstract][Full Text] [Related]
2. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
[TBL] [Abstract][Full Text] [Related]
3. neu/ERBB2 cooperates with p53-172H during mammary tumorigenesis in transgenic mice.
Li B; Rosen JM; McMenamin-Balano J; Muller WJ; Perkins AS
Mol Cell Biol; 1997 Jun; 17(6):3155-63. PubMed ID: 9154814
[TBL] [Abstract][Full Text] [Related]
4. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
[TBL] [Abstract][Full Text] [Related]
5. Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease.
Qiu TH; Chandramouli GV; Hunter KW; Alkharouf NW; Green JE; Liu ET
Cancer Res; 2004 Sep; 64(17):5973-81. PubMed ID: 15342376
[TBL] [Abstract][Full Text] [Related]
6. MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer.
Theodorou V; Kimm MA; Boer M; Wessels L; Theelen W; Jonkers J; Hilkens J
Nat Genet; 2007 Jun; 39(6):759-69. PubMed ID: 17468756
[TBL] [Abstract][Full Text] [Related]
7. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice.
Elson A; Deng C; Campos-Torres J; Donehower LA; Leder P
Oncogene; 1995 Jul; 11(1):181-90. PubMed ID: 7624126
[TBL] [Abstract][Full Text] [Related]
8. Genes affected by mouse mammary tumor virus (MMTV) proviral insertions in mouse mammary tumors are deregulated or mutated in primary human mammary tumors.
Callahan R; Mudunur U; Bargo S; Raafat A; McCurdy D; Boulanger C; Lowther W; Stephens R; Luke BT; Stewart C; Wu X; Munroe D; Smith GH
Oncotarget; 2012 Nov; 3(11):1320-34. PubMed ID: 23131872
[TBL] [Abstract][Full Text] [Related]
9. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice.
Kapoun AM; Shackleford GM
Oncogene; 1997 Jun; 14(24):2985-9. PubMed ID: 9205106
[TBL] [Abstract][Full Text] [Related]
10. Fgf-8, activated by proviral insertion, cooperates with the Wnt-1 transgene in murine mammary tumorigenesis.
MacArthur CA; Shankar DB; Shackleford GM
J Virol; 1995 Apr; 69(4):2501-7. PubMed ID: 7884899
[TBL] [Abstract][Full Text] [Related]
11. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E
BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875
[TBL] [Abstract][Full Text] [Related]
12. RIII/Sa mice with a high incidence of mammary tumors express two exogenous strains and one potential endogenous strain of mouse mammary tumor virus.
Sarkar NH; Golovkina T; Uz-Zaman T
J Virol; 2004 Jan; 78(2):1055-62. PubMed ID: 14694140
[TBL] [Abstract][Full Text] [Related]
13. Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.
Landis MD; Seachrist DD; Abdul-Karim FW; Keri RA
Oncogene; 2006 Jun; 25(23):3325-34. PubMed ID: 16434967
[TBL] [Abstract][Full Text] [Related]
14. In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53.
Hosokawa Y; Papanikolaou A; Cardiff RD; Yoshimoto K; Bernstein M; Wang TC; Schmidt EV; Arnold A
Transgenic Res; 2001 Oct; 10(5):471-8. PubMed ID: 11708657
[TBL] [Abstract][Full Text] [Related]
15. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis.
Gallahan D; Jhappan C; Robinson G; Hennighausen L; Sharp R; Kordon E; Callahan R; Merlino G; Smith GH
Cancer Res; 1996 Apr; 56(8):1775-85. PubMed ID: 8620493
[TBL] [Abstract][Full Text] [Related]
16. Cooperative induction of mammary tumorigenesis by TGFalpha and Wnts.
Schroeder JA; Troyer KL; Lee DC
Oncogene; 2000 Jun; 19(28):3193-9. PubMed ID: 10918574
[TBL] [Abstract][Full Text] [Related]
17. Stem cells and mammary cancer in mice.
Smith GH
Stem Cell Rev; 2005; 1(3):215-23. PubMed ID: 17142858
[TBL] [Abstract][Full Text] [Related]
18. Mouse mammary tumor virus infection accelerates mammary carcinogenesis in Wnt-1 transgenic mice by insertional activation of int-2/Fgf-3 and hst/Fgf-4.
Shackleford GM; MacArthur CA; Kwan HC; Varmus HE
Proc Natl Acad Sci U S A; 1993 Jan; 90(2):740-4. PubMed ID: 8380647
[TBL] [Abstract][Full Text] [Related]
19. Impairment of mammary lobular development induced by expression of TGFbeta1 under the control of WAP promoter does not suppress tumorigenesis in MMTV-infected transgenic mice.
Buggiano V; Schere-Levy C; Abe K; Vanzulli S; Piazzon I; Smith GH; Kordon EC
Int J Cancer; 2001 May; 92(4):568-76. PubMed ID: 11304693
[TBL] [Abstract][Full Text] [Related]
20. MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia.
Daphna-Iken D; Shankar DB; Lawshé A; Ornitz DM; Shackleford GM; MacArthur CA
Oncogene; 1998 Nov; 17(21):2711-7. PubMed ID: 9840935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]